SE462562B - Dikloranilinderivat, foerfarande foer framstaellning av dessa och en farmaceutisk komposition - Google Patents

Dikloranilinderivat, foerfarande foer framstaellning av dessa och en farmaceutisk komposition

Info

Publication number
SE462562B
SE462562B SE8700535A SE8700535A SE462562B SE 462562 B SE462562 B SE 462562B SE 8700535 A SE8700535 A SE 8700535A SE 8700535 A SE8700535 A SE 8700535A SE 462562 B SE462562 B SE 462562B
Authority
SE
Sweden
Prior art keywords
group
amino
pyridinyl
hydrogen atom
methyl
Prior art date
Application number
SE8700535A
Other languages
English (en)
Swedish (sv)
Other versions
SE8700535D0 (sv
SE8700535L (sv
Inventor
L H C Lunts
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of SE8700535D0 publication Critical patent/SE8700535D0/xx
Publication of SE8700535L publication Critical patent/SE8700535L/xx
Publication of SE462562B publication Critical patent/SE462562B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE8700535A 1986-02-12 1987-02-11 Dikloranilinderivat, foerfarande foer framstaellning av dessa och en farmaceutisk komposition SE462562B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868603475A GB8603475D0 (en) 1986-02-12 1986-02-12 Chemical compounds

Publications (3)

Publication Number Publication Date
SE8700535D0 SE8700535D0 (sv) 1987-02-11
SE8700535L SE8700535L (sv) 1987-08-13
SE462562B true SE462562B (sv) 1990-07-16

Family

ID=10592944

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8700535A SE462562B (sv) 1986-02-12 1987-02-11 Dikloranilinderivat, foerfarande foer framstaellning av dessa och en farmaceutisk komposition

Country Status (37)

Country Link
US (1) US4937251A (fi)
JP (2) JPS62258359A (fi)
KR (1) KR870007886A (fi)
CN (1) CN1020095C (fi)
AT (1) AT394364B (fi)
AU (1) AU596824B2 (fi)
BE (1) BE1002129A3 (fi)
CA (1) CA1301762C (fi)
CH (1) CH670636A5 (fi)
CS (1) CS402991A3 (fi)
CY (1) CY1660A (fi)
DE (1) DE3704223C2 (fi)
DK (1) DK163991C (fi)
ES (1) ES2004676A6 (fi)
FI (1) FI83774C (fi)
FR (1) FR2596049B1 (fi)
GB (2) GB8603475D0 (fi)
GR (1) GR870220B (fi)
HK (1) HK85790A (fi)
HU (1) HU199416B (fi)
IE (1) IE59524B1 (fi)
IL (2) IL81535A (fi)
IS (1) IS1489B (fi)
IT (1) IT1205978B (fi)
LU (1) LU86768A1 (fi)
MX (1) MX5220A (fi)
NL (1) NL188408C (fi)
NO (1) NO170629C (fi)
NZ (1) NZ219241A (fi)
PH (1) PH24067A (fi)
PL (1) PL151050B1 (fi)
PT (1) PT84273B (fi)
SE (1) SE462562B (fi)
SG (1) SG70590G (fi)
SU (1) SU1590042A3 (fi)
ZA (1) ZA87974B (fi)
ZW (1) ZW2887A1 (fi)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8703007D0 (en) * 1987-02-10 1987-03-18 Glaxo Group Ltd Chemical compounds
GB8718939D0 (en) * 1987-08-11 1987-09-16 Glaxo Group Ltd Chemical compounds
US5149698A (en) * 1987-08-11 1992-09-22 Glaxo Group Limited Chloroaniline derivatives
ES2039646T3 (es) * 1987-11-13 1993-10-01 Glaxo Group Limited Derivados de fenetanolamina.
FR2662691A1 (fr) * 1990-06-05 1991-12-06 Glaxo Group Ltd Derive de la dichloroaniline.
GB9104650D0 (en) * 1991-03-05 1991-04-17 Glaxo Group Ltd Medicaments
US6419873B1 (en) 1999-03-19 2002-07-16 Q2100, Inc. Plastic lens systems, compositions, and methods
US6436972B1 (en) 2000-04-10 2002-08-20 Dalhousie University Pyridones and their use as modulators of serine hydrolase enzymes
TWI249515B (en) 2001-11-13 2006-02-21 Theravance Inc Aryl aniline beta2 adrenergic receptor agonists
WO2003107018A1 (ja) * 2002-06-18 2003-12-24 旭化成株式会社 電流測定方法および電流測定装置
US20070219223A1 (en) * 2006-03-07 2007-09-20 Endacea, Inc. Compositions and methods for treating respiratory disorders
JP5626621B2 (ja) 2010-03-19 2014-11-19 株式会社 日立産業制御ソリューションズ フェイズドアレイ合成開口ソナーシステム
PE20221914A1 (es) 2011-12-28 2022-12-23 Global Blood Therapeutics Inc Compuestos de benzaldehido sustituidos y metodos para su uso en incrementar la oxigenacion del tejido
EP2797597B1 (en) 2011-12-28 2020-02-26 Global Blood Therapeutics, Inc. Substituted heteroaryl aldehyde compounds and methods for their use in increasing tissue oxygenation
US9422279B2 (en) 2013-03-15 2016-08-23 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
AU2014237348C1 (en) 2013-03-15 2019-02-07 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US20140274961A1 (en) 2013-03-15 2014-09-18 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
WO2014145040A1 (en) 2013-03-15 2014-09-18 Global Blood Therapeutics, Inc. Substituted aldehyde compounds and methods for their use in increasing tissue oxygenation
US9802900B2 (en) 2013-03-15 2017-10-31 Global Blood Therapeutics, Inc. Bicyclic heteroaryl compounds and uses thereof for the modulation of hemoglobin
US8952171B2 (en) 2013-03-15 2015-02-10 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US9458139B2 (en) 2013-03-15 2016-10-04 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US10266551B2 (en) 2013-03-15 2019-04-23 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
MY191087A (en) 2013-03-15 2022-05-30 Global Blood Therapeutics Inc Compounds and uses thereof for the modulation of hemoglobin
US9604999B2 (en) 2013-03-15 2017-03-28 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
PE20160078A1 (es) 2013-03-15 2016-03-02 Global Blood Therapeutics Inc Compuestos y sus usos para modular la hemoglobina
EA202092627A1 (ru) 2013-11-18 2021-09-30 Глобал Блад Терапьютикс, Инк. Соединения и их применения для модуляции гемоглобина
CN105431147A (zh) 2014-02-07 2016-03-23 全球血液疗法股份有限公司 2-羟基-6-((2-(1-异丙基-1h-吡唑-5-基)吡啶-3-基)甲氧基)苯甲醛的游离碱的结晶多晶型物
MA41841A (fr) 2015-03-30 2018-02-06 Global Blood Therapeutics Inc Composés aldéhyde pour le traitement de la fibrose pulmonaire, de l'hypoxie, et de maladies auto-immunes et des tissus conjonctifs
WO2017096230A1 (en) 2015-12-04 2017-06-08 Global Blood Therapeutics, Inc. Dosing regimens for 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde
TWI825524B (zh) 2016-05-12 2023-12-11 美商全球血液治療公司 用於合成2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)-吡啶-3-基)甲氧基)苯甲醛之方法
TW202332423A (zh) 2016-10-12 2023-08-16 美商全球血液治療公司 包含2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)吡啶-3-基)甲氧基)-苯甲醛之片劑
EP3860975B1 (en) 2018-10-01 2023-10-18 Global Blood Therapeutics, Inc. Modulators of hemoglobin for the treatment of sickle cell disease

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1618005A1 (de) * 1966-09-22 1971-09-09 Thomae Gmbh Dr K Verfahren zur Herstellung von neuen Amino-dihalogen-phenyl-aethylaminen
NL176168C (nl) * 1972-12-18 1985-03-01 Thomae Gmbh Dr K Werkwijze ter bereiding respectievelijk vervaardiging van een farmaceutisch preparaat en werkwijze ter bereiding van daarbij bruikbare nieuwe gesubstitueerde 1-(4-aminofenyl)-2-amino-ethanol-derivaten die, behalve een analgetische, uterusspasmolytische en anti-spastische werking op de dwarsgestreepte spieren, in het bijzonder een betaŸ2-mimetische en/of betaŸ1-blokkerende werking bezitten.
DE2711655A1 (de) * 1977-03-17 1978-09-21 Basf Ag Pyridinyl-aminoalkylaether
CH635320A5 (en) * 1978-01-01 1983-03-31 Ciba Geigy Ag 1-(Azacyclic aralkoxyphenyl)-2- or -3-(bis-arylalkylamino)alkanes
ATE1899T1 (de) * 1979-06-16 1982-12-15 Beecham Group Plc Sekundaere amine, ihre herstellung und verwendung in pharmazeutischen zusammensetzungen.
NL8105170A (nl) * 1980-12-10 1982-07-01 Thomae Gmbh Dr K Nieuwe fenylalkylaminen, werkwijze ter bereiding daarvan en de toepassing daarvan als geneesmiddelen.
US4379166A (en) * 1981-08-03 1983-04-05 Schering Corporation Arylmethoxy-, arylmethylthio-, heteroarylmethoxy-, and heteroarylmethylthio-alkylaminoalcohols
HU186654B (en) * 1982-12-28 1985-09-30 Richter Gedeon Vegyeszet Process for producing new pyridine derivatives, acid additional salts and quaternary salts and pharmaceutical compositions containing them
DE3434271A1 (de) * 1984-09-19 1986-03-20 Beiersdorf Ag, 2000 Hamburg Substituierte 3,4-dihydro-chinolin-2(1h)-one verfahren zu ihrer herstellung und ihre verwendung sowie diese verbindungen enthaltende zubereitungen
GB8426191D0 (en) * 1984-10-17 1984-11-21 Glaxo Holdings Ltd Chemical compounds
GB8525484D0 (en) * 1985-10-16 1985-11-20 Glaxo Group Ltd Chemical compounds
GB8718939D0 (en) * 1987-08-11 1987-09-16 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
AT394364B (de) 1992-03-25
NL188408C (nl) 1992-06-16
DE3704223C2 (de) 1995-05-24
JPH0462311B2 (fi) 1992-10-05
CN1020095C (zh) 1993-03-17
PL151050B1 (en) 1990-07-31
DK69887D0 (da) 1987-02-11
IL81535A (en) 1990-11-05
PH24067A (en) 1990-03-05
IL81535A0 (en) 1987-09-16
ZW2887A1 (en) 1987-09-23
HUT43566A (en) 1987-11-30
FI870554A0 (fi) 1987-02-11
MX5220A (es) 1993-11-01
ATA28687A (de) 1991-09-15
CH670636A5 (fi) 1989-06-30
JPH0314565A (ja) 1991-01-23
ES2004676A6 (es) 1989-02-01
FR2596049A1 (fr) 1987-09-25
GB2187734B (en) 1990-05-30
AU6869587A (en) 1987-08-13
PT84273B (pt) 1989-09-14
HK85790A (en) 1990-10-25
JPS62258359A (ja) 1987-11-10
FI83774B (fi) 1991-05-15
IE59524B1 (en) 1994-03-09
SE8700535D0 (sv) 1987-02-11
GB8703059D0 (en) 1987-03-18
CS402991A3 (en) 1992-09-16
CN87101830A (zh) 1987-09-09
IT8747630A0 (it) 1987-02-11
IS3193A7 (is) 1987-08-13
SG70590G (en) 1990-10-26
CA1301762C (en) 1992-05-26
HU199416B (en) 1990-02-28
US4937251A (en) 1990-06-26
DK163991C (da) 1992-09-21
NL188408B (nl) 1992-01-16
DK69887A (da) 1987-08-13
NL8700326A (nl) 1987-09-01
IE870350L (en) 1987-08-12
GB2187734A (en) 1987-09-16
IL89205A (en) 1993-04-04
CY1660A (en) 1993-05-14
IS1489B (is) 1992-06-30
AU596824B2 (en) 1990-05-17
ZA87974B (en) 1987-12-30
DK163991B (da) 1992-04-27
PL264054A1 (en) 1988-10-13
NO170629B (no) 1992-08-03
NO870526L (no) 1987-08-13
NO170629C (no) 1992-11-11
GB8603475D0 (en) 1986-03-19
SU1590042A3 (ru) 1990-08-30
LU86768A1 (fr) 1988-03-02
FI83774C (fi) 1991-08-26
SE8700535L (sv) 1987-08-13
BE1002129A3 (fr) 1990-07-24
PT84273A (en) 1987-03-01
FR2596049B1 (fr) 1991-02-08
NO870526D0 (no) 1987-02-11
NZ219241A (en) 1990-01-29
GR870220B (en) 1987-05-28
FI870554A (fi) 1987-08-13
IT1205978B (it) 1989-04-05
KR870007886A (ko) 1987-09-22
DE3704223A1 (de) 1987-08-20

Similar Documents

Publication Publication Date Title
SE462562B (sv) Dikloranilinderivat, foerfarande foer framstaellning av dessa och en farmaceutisk komposition
DK167493B1 (da) Phenethanolaminderivater og fysiologisk acceptable syreadditionssalte og solvater deraf og et farmaceutisk praeparat deraf
US6281214B1 (en) Biphenyl derivatives
US4963564A (en) Phenethanolamine derivatives
EP0162576B1 (en) Ethanolamine compounds
JP3047470B2 (ja) 中枢神経系剤としての置換されたテトラヒドロピリジンおよびヒドロキシピペリジン
US4412856A (en) Herbicidal heterocyclic and substituted phenyl phenylacetylene amines
NL8502012A (nl) Aminofenolverbindingen.
JPS61143346A (ja) ジクロルアニリン誘導体
US4322418A (en) Substituted 1-(α-aminocarbonyl-benzyl)-3,4-dihydro-isoquinolines, compositions and use
SI9300542A (en) Benzofuran derivatives for medical use
JPH0375542B2 (fi)
JPS60120866A (ja) 新規カルボスチリル誘導体
SE467541B (sv) Dikloranilinderivat, foerfaranden foer framstaellning daerav samt farmaceutiska kompositioner
US4996218A (en) Chloroaniline derivatives
US4514573A (en) Isoprenylamine derivatives
US4921867A (en) Pyridine compounds useful for therapy or prophylaxis of a disease associated with airway obstruction
JP3902801B2 (ja) ビフェニル誘導体
US5149698A (en) Chloroaniline derivatives

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8700535-1

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8700535-1

Format of ref document f/p: F